Back to Search
Start Over
FDA approves Genentech's drug for late-stage metastatic breast cancer
- Source :
- Chemical Business Newsbase. February 22, 2013
- Publication Year :
- 2013
-
Abstract
- Genentech announced that the US Food and Drug Administration (FDA) has approved Kadcyla (ado-trastuzumab emtansine or T-DM1) for the treatment of people with HER2-positive metastatic breast cancer (mBC) who have [...]
- Subjects :
- United States. Food and Drug Administration
Genentech Inc.
Biological products industry
Metastasis -- Drug therapy
Antineoplastic agents
Biotechnology industry
Drug approval
Chemotherapy
Cancer -- Chemotherapy
Breast cancer -- Drug therapy
Antimitotic agents
Business
Chemicals, plastics and rubber industries
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Chemical Business Newsbase
- Publication Type :
- News
- Accession number :
- edsgcl.320827780